European Journal of Cancer
Volume 46, Issue 5 , Pages 856-858 , March 2010

Staging early ovarian cancer: Impact on treatment decisions

Received 11 January 2010 ,Accepted 14 January 2010.

References 

  1. Tropé C, Kaern . Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature. J Cin Oncol. 2007;25:2909–2920
  2. Winter-Roach BA, Kitchener HC, Dickinson HO. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer (review). The Cochrane Collaboration. The Cochrane Library. John Wiley & Sons Ltd; 2009.
  3. Baptist Trimbos J, Vergote I, Bolis G, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European organization for research and treatment of cancer-adjuvant chemotherapy in ovarian neoplasm trial. J Natl Cancer Inst. 2003;95:113–125
  4. International Collaborative Ovarian Neoplasm (ICON1) Collaborators. International collaborative ovarian neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst. 2003;95:125–132
  5. International Collaborative Ovarian Neoplasm (ICON1) and European Organisation for Research and Treatment of Cancer Collaborators—Adjuvant ChemoTherapy in Ovarian Neoplasm (EORTC-ACTION). International collaborative ovarian neoplasm Trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003; 95:105–12.
  6. Bolis G, Colombo N, Pecorelli S, et al. Adjuvant treatment for early epithelial ovarian cancer: results of two randomized clinical trials comparing cisplating to no further treatment of chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia Oncologica. Ann Oncol. 1995;6:887–893
  7. Vernooij F, Heintz APM, Coebergh JW, et al. Specialized and high-volume care leads to better outcomes of ovarian cancer in the Netherlands. Gynecol Oncol. 2009;112:455–461
  8. Bagley CM, Young RC, Schein PS, Chabner BA, DeVita VT. Ovarian carcinoma metastatic to the diaphragm—frequently undiagnosed at laparotomy. A preliminary report. Am J Obstet Gynecol. 1973;116:397–400
  9. Soper JT, Johnson P, Johnson V, Berchuck A, Clarke-Pearson DL. Comprehensive restaging laparotomy in women with apparently early ovarian carcinoma. Obstet Gynecol. 1992;80:949–953
  10. Maggioni A, Panici PB, Dell’Anna T, et al. Randomised study of systemic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;95:699–704
  11. Kolomainen DF, A’Hern R, Coxon FY, et al. Can patients with relapsed, previously untreated, stage I epithelial ovarian cancer be successfully treated with salvage therapy. J Clin Oncol. 2003;21:3113–3118
  12. Bell J, Brady MF, Young RC, et al. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group Study. Gynecol Oncol. 2006;102:432–439
  13. Markman M. To the Editor: randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group Study. Gynecol Oncol. 2007;105:279–280
  14. Verleye L, Ottevanger PB, van der Graaf W, et al. EORTC-GCG process quality indicators for ovarian cancer surgery. Eur J Cancer. 2009;45:517–526
  15. Chi DS, Abu-Rustum NR, Sonoda Y, et al. The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers. Am J Obstet Gynecol. 2005;192:1614–1619

PII: S0959-8049(10)00036-5

doi: 10.1016/j.ejca.2010.01.017

European Journal of Cancer
Volume 46, Issue 5 , Pages 856-858 , March 2010

Article Tools